WB
The startup develops next-generation anticancer drugs utilizing metabolic disease and muscle-related biomarkers, alongside diagnostic kits to enhance patient care. By establishing a digital healthcare platform, the company aims to provide targeted therapies that address the limitations of current cancer treatments, improving outcomes for patients.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops next-generation anticancer drugs utilizing metabolic disease and muscle-related biomarkers, alongside diagnostic kits to enhance patient care. By establishing a digital healthcare platform, the company aims to provide targeted therapies that address the limitations of current cancer treatments, improving outcomes for patients.